• Strawberry Fields REIT, Inc., is a self-administered real estate investment trust, focused on the acquisition of properties that are leased out to skilled nursing and other healthcare businesses
• While appearing on The Bell2Bell Podcast, the company’s CEO, Moishe Gubin, reflected on the strides made thus far, the milestones achieved, and the company’s future
• Most notably, Gubin noted the company distributes less than 50% of its AFFO, with the remaining 50% allocated to additional asset purchases which has led to the growth of its AFFO per share of 11% annually
• He continued to reiterate the company’s commitment to building facilities for America’s rapidly increasing aging population

Strawberry Fields REIT (NYSE: AMERICAN: STRW), a self-administered real estate investment trust engaged in the ownership, acquisition, and leasing of skilled nursing and specific other healthcare-related properties, is celebrating 10 years of operation. While appearing on The Bell2Bell Podcast, CEO Moishe Gubin reflected on the company’s success, the milestones it has achieved, and where the company is headed going forward (https://ibn.fm/A1kOf).

Notably, the company has demonstrated impeccable financial discipline and consistency. Gubin noted that the company only distributes 45% to 50% of its Adjusted Funds From Operation (“AFFO”), with the remaining 50% allocated to additional asset purchases, a move that has led to the consistent growth of its value per share at an annual rate of 11%.

“I think our stock is perfect for a more conservative investment with a better yield,” he noted. “We only distribute 45% or 50%. The other 50% is used to buy more assets, and therefore we are growing the AFFO per share at an 11% clip annually,” he added (https://ibn.fm/A1kOf).

This level of success, Gubin noted, can be attributed to the company’s leadership’s understanding of the market, particularly given their operational backgrounds. It’s important to note that the company does not operate these centers but rather acquires and develops appropriate properties that are then leased out to skilled nursing and other healthcare businesses. Gubin and his business partner and Board Member, Michael Blisko, were able to recognize the many intricacies of the healthcare facility business – what works best, and how to address challenges that arise. 

As a result, in its 10+ years of operation, having refined its company evaluation to a science, Strawberry Fields has never seen a missed rent payment, collecting 100% of its rents.

“We evaluate a company as if we were going to be operating it: what deal would we make, how would we buy, what kind of services would we provide?” noted Gubin. “It’s an advantage, because if something goes bad, we can stabilize it and fix a problem before it becomes a big loss,” he added (https://ibn.fm/A1kOf).

Gubin noted that collectively, all these aspects have played a key role in Strawberry Fields’ growth. Today, the company has facilities spread across 10 states, primarily comprised of skilled nursing facilities, a few hospitals, and assisted living facilities. Gubin further noted that the company’s future looks bright and continues to affirm its commitment to owning and leasing facilities for America’s growing aging population.

For company information, visit the company’s website at www.StrawberryFieldsREIT.com

To hear the episode and subscribe for future podcasts, please visit Podcast.Bell2Bell.com

NOTE TO INVESTORS: The latest news and updates relating to STRW are available in the company’s newsroom at https://ibn.fm/STRW

• SEGG Media has recently expanded its offering by launching SEGG Digital and SEGG Productions.
• The company also created a new corporate website to position itself as a forward-thinking brand amid the beginning of their next phase of growth.
• It also recently had representatives from its executive team in Nashville for the season finale of IndyCar, to support the SEGG Media-backed drivers, finalized sponsorships, and to kick the tires on the 2026 SEGG Elite Driver Program.
• SEGG Media kicked off the next stage of its progression thanks to strategic acquisitions, strong capital, and global expansion.

On the heels of its rebranding, SEGG Media (NASDAQ: SEGG, LTRYW) has made several recent announcement showcasing its growth and expansion as an organization.

The company recently launched two new operations: SEGG Digital and SEGG Productions. These launches are focused on expanding brand influence, growing the SEGG Media audience, and creating new sources of revenue.

SEGG Digital is the new global marketing arm for the organization, and will work on various social media strategies, influencer marketing initiatives, and more. On the other hand, SEGG Productions will be all about telling original stories across industries like music, entertainment, and lifestyle.

In addition to launching these new arms of SEGG Media, the company also recently revealed a new corporate website. The new branding, kicking off with seggmediacorp.com, will serve as a digital hub for the organization, providing a portal for stakeholders to access the company’s corporate identity, provide transparency and direct access to their portfolio of brands. 

The organization also had some executives head to Nashville to attend the Borchetta Bourbon Music City Grand Prix, which was the final race of the 2025 INDYCAR season. This included CEO, President, and Chairman Matthew McGahan, COO Gregory Potts, and Board Director Warren Macal.

The group was there to support the three SEGG Media-backed drives (Callum Ilott, Louis Foster, and Seb Murray), work on future sponsorships, and finalize the Elite Driver Program for the 2026 season.

Finally, SEGG Media recently announced it has moved into the next step of its progression as a company. Backed by $450 million in financing, the company is expecting to make numerous acquisitions to speed up market penetration and have strategic partnerships to expand its brand across sports, entertainment, media, and more.

The organization is also focusing more on immersive fan engagement and AI-driven experiences and is expanding into new international markets in the Middle East, Europe, and the Americas.

SEGG Media Corp. is a global sports, entertainment, and gaming organization that’s all about connecting people to experiences. The company owns and operates a portfolio of impressive digital assets like Sports.com, Lottery.com, and Concerts.com.

For more information, visit the company’s website at SEGGMediaCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to SEGG are available in the company’s newsroom at https://ibn.fm/SEGG

• Soligenix is positioning itself to expand its presence in dermatology with a novel therapeutic option for one of the most prevalent autoimmune skin conditions.
• The company’s current study aims to further assess safety and biological activity of SGX302, as well as generate additional data to guide larger studies.
• SGX302 has already demonstrated positive results in a phase 1/2 pilot study.

Psoriasis remains a persistent challenge for millions of patients worldwide, and promising new treatments are being closely watched by the medical and investor communities alike. Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on rare diseases and inflammatory conditions, is advancing its treatment candidate, SGX302, in a phase 2a clinical trial for mild-to-moderate psoriasis. The company has already seen encouraging signals in earlier proof-of-concept work, and with its current study underway, Soligenix is positioning itself to expand its presence in dermatology with a novel therapeutic option for one of the most prevalent autoimmune skin conditions.

The psoriasis trial, officially registered as NCT05442190, is designed as a phase 2a open-label study evaluating SGX302, a synthetic hypericin formulation, in patients with mild-to-moderate disease. Building on earlier positive phase 1/2 proof-of-concept data, this current study aims to further assess safety and biological activity, as well as generate additional data to guide larger studies. According to Soligenix, positive outcomes have already been observed in select patients within the first two cohorts of the trial, giving the company confidence in the potential of SGX302 (https://ibn.fm/dqtUu).

Psoriasis is not just a cosmetic concern; it is a chronic, inflammatory condition with significant physical and psychological impact. The American Academy of Dermatology estimates that more than 7.5 million people in the United States are affected by psoriasis, with millions more across Europe and globally (https://ibn.fm/nTANg). Within this group, a large percentage experience mild-to-moderate disease, representing a substantial addressable market for effective treatments.

Existing therapies can be expensive or carry safety concerns when used long-term, creating a demand for novel approaches that balance efficacy with tolerability. Leveraging the same synthetic hypericin platform as Soligenix’s HyBryte(TM) for cutaneous T-cell lymphoma, SGX302 offers a unique mechanism that may deliver sustained benefits without the drawbacks associated with some conventional systemic or biologic therapies.

Soligenix reports that SGX302 has already demonstrated positive results in a phase 1/2 pilot study. In the current phase 2a study, markers of clinical success have been noted in two of the four patients treated in cohort 2. While results remain preliminary, they add to a growing body of evidence that SGX302 could become a viable option in a global psoriasis treatment market that Soligenix notes is projected to reach as much as $67 billion by 2030 (https://ibn.fm/TB3hi). Importantly, the company’s progress with SGX302 builds on its expertise with synthetic hypericin, already advanced into late-stage development in other dermatologic conditions, providing a degree of de-risking to the psoriasis program.

For investors, the potential here is twofold. First, the psoriasis program addresses a widespread, mainstream condition with substantial commercial upside. Second, Soligenix has a pipeline strategy that leverages synergies across its biotherapeutics business segment. Success with SGX302 would not only open the door to a large market but also validate the company’s broader approach of applying synthetic hypericin across multiple indications. With its dual business model that includes both biotherapeutics and public health solutions, Soligenix has benefited from diversification, nondilutive government support, and opportunities for near- and long-term value creation.

Expectations for ongoing results remain high. The phase 2a trial continues enrollment, with expanded clinical readouts anticipated in the near-term. If outcomes align with early signals, Soligenix may advance into a more definitive study designed to secure regulatory guidance and pave the way toward commercialization. Given the strong safety data to date and the unmet need for new and safer psoriasis treatments, SGX302 could be a meaningful addition to the treatment landscape if development milestones are successfully achieved.

Soligenix’s track record in advancing rare-disease therapies, along with its experience in managing complex regulatory pathways, positions the company well to continue making progress in this space. As psoriasis patients and physicians alike seek more options that are effective, safe and accessible, the company’s ongoing trial of SGX302 offers hope for an innovative alternative. For investors, the unfolding results of this trial provide a critical catalyst, underscoring why Soligenix’s work in psoriasis is a story worth following.

For more information, visit www.Soligenix.com.

NOTE TO INVESTORS: The latest news and updates relating to SNGX are available in the company’s newsroom at https://ibn.fm/SNGX

• CMS proposal keeps CT radiation quality measure voluntary, highlighting ongoing debate around dose safety and image quality
• Izotropic’s IzoView breast CT system engineered to deliver low-dose, high-resolution 3D imaging, aligning with future regulatory and clinical priorities
• Company launches new FAQ page to enhance transparency for investors, clinicians, and decision-makers

In medical imaging, technology often races ahead of regulation. A recent proposal from the Centers for Medicare & Medicaid Services (CMS) underscores this tension: the agency is opting not to mandate radiation dose tracking for CT scans by 2027. While the decision reflects operational challenges hospitals face in meeting such requirements, it also highlights a growing consensus: patients, providers, and regulators all want sharper images with lower radiation exposure.

As CT utilization continues to expand, the industry sits at a crossroads. Balancing image clarity with radiation safety is no longer just a technical issue; it is becoming central to policy, reimbursement, and patient advocacy. For innovators in breast imaging, this is both a challenge and an opportunity.

Izotropic’s Purpose-Built Approach

Izotropic (CSE: IZO) (OTCQB: IZOZF) is positioning itself within this evolving dialogue. The company’s flagship product, IzoView, is a dedicated breast CT system designed to address the dual goals of radiation dose reduction and ultra-high-resolution imaging.

IzoView offers true 360-degree 3D imaging without compression, creating a more comfortable experience for patients while and may improve diagnostic confidence for clinicians. Its design prioritizes radiation efficiency without sacrificing image quality, a combination that speaks directly to the concerns driving CMS deliberations and radiology community debates.

By engineering a system that anticipates tomorrow’s quality measures, Izotropic may offer hospitals and clinics a future-ready solution in an environment where dose tracking, safety, and diagnostic precision are increasingly non-negotiable.

Transparency and Engagement Through New FAQ Resource

In parallel with its technological development, Izotropic is also working to strengthen communication with stakeholders. The company recently announced the launch of a Frequently Asked Questions (FAQ) page on its corporate website.

This resource provides investors, analysts, clinicians, and healthcare decision-makers with clear information about IzoView’s positioning, imaging workflow, and comparisons to mammography, ultrasound, and MRI. It also explains the clinical relevance of dense breast tissue, a key challenge in cancer detection, and underscores Izotropic’s exclusive commercialization rights for breast CT technology developed at the University of California, Davis.

Optimized for search engines and AI platforms, the FAQ page enhances discoverability and supports outreach to media, clinical audiences, and investors. Importantly, it reflects the company’s commitment to transparency as it advances through clinical trials, FDA review, and eventual commercialization.

Market Implications in Breast Imaging

The breast imaging market remains dominated by mammography, despite its limitations in patients with dense breast tissue. Supplemental methods such as ultrasound and MRI fill some gaps but carry trade-offs in cost, accessibility, or workflow efficiency.

IzoView’s combination of non-compression imaging, high-resolution detail, and radiation management creates a differentiated option. For hospitals navigating voluntary-but-encouraged CMS reporting measures, investing in technologies engineered for higher standards could mitigate future regulatory risk while improving patient outcomes.

As regulators, clinicians, and patient advocates continue to press for safer, higher-quality imaging, Izotropic’s technology arrives at a timely moment. If dose reporting becomes mandatory in the future, as many experts believe it eventually will, hospitals adopting systems like IzoView may be better prepared to comply without major workflow disruption.

Positioning for Long-Term Growth

Izotropic’s dual focus on innovation and transparent communication reinforces its strategic positioning. On the technical side, IzoView addresses both immediate clinical needs and anticipated regulatory requirements. On the communication side, the new FAQ page strengthens investor confidence and equips healthcare decision-makers with essential knowledge.

With its regulatory pathway in progress, Izotropic is aligning itself with both market demand and policy direction. Whether or not CMS makes dose reporting mandatory in the near term, the broader push toward radiation safety and high-resolution imaging is unlikely to reverse course.

For investors, this alignment between regulatory trends and clinical needs represents a notable opportunity. Izotropic is not simply developing imaging hardware; it is building a platform that anticipates where the standards of care are heading.

For more information, visit the company’s website at www.IzoCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to IZOZF are available in the company’s newsroom at ibn.fm/IZOZF

• Silvercorp has a stated mandate to grow through acquisitions.
• The company’s profitable operations in China are complemented by construction and development stage projects in Ecuador.
• Recent financial results show rising revenue and cash flow, giving management a strong foundation for future strategic moves.
• Silvercorp renewed its base shelf prospectus in Canada and the U.S., after the previous one expired, qualifying up to US$400 million in securities over 25 months, positioning the company with flexibility to issue shares, debt, warrants, or units, based upon market conditions.

Silvercorp Metals (NYSE American/TSX: SVM), a Canadian mining company producing silver, gold, lead, and zinc, has filed a base shelf prospectus with Canadian regulators and a corresponding registration statement with the U.S. Securities and Exchange Commission. The filings, effective for 25 months, qualify Silvercorp to raise up to US$400 million in securities, with flexibility depending upon market conditions (https://ibn.fm/gPj6p).

The new shelf prospectus signals a clear intent to maintain readiness. Speaking with management, the company has expressed interest in acquisitions to further drive growth and diversification, and the shelf provides flexibility to raise funds quickly and efficiently.

A shelf prospectus is a standard financial tool and does not obligate Silvercorp to raise money. Instead, it gives the company flexibility to issue common or preferred shares, debt instruments, subscription receipts, warrants, or units, in various forms such as public offerings, private placements, or “at-the-market” transactions, depending on regulatory and market conditions. Having a shelf in place positions Silvercorp to act swiftly on opportunities such as mergers, acquisitions, or capital-intensive growth projects. For mining companies, where timing can be critical, this flexibility is an important part of long-term capital strategy. Specific terms would be disclosed in supplements if and when securities are offered. ,. Silvercorp has historically maintained a base shelf prospectus as part of its capital strategy.

Besides the new shelf, Silvercorp’s position is further bolstered by recently reported financial results. In the fourth quarter of fiscal 2025, Silvercorp reported revenue of $75.1 million, up 76% year-over-year. Operating cash flow nearly tripled to $30.7 million, compared with $10.2 million in the prior-year quarter.

Continuing the trend, the company opened its 2026 fiscal year with stronger production volumes and a notable rise in revenues, while continuing to advance its growth projects in China and Ecuador. More specifically, in Q1 FY2026, Silvercorp generated $81.3 million in revenue, a 13% increase year-over-year, reported higher adjusted net income of $21.0 million, and produced 2.0 million ounces of silver equivalent, including 1.8 million ounces of silver and 2,050 ounces of gold. These figures underpin record cash flow generation, further strengthening the balance sheet to support growth.

Silvercorp’s operating base includes the Ying Mining District in Henan Province, China, and the GC mine west of Guangzhou. Beyond China, the company is building the El Domo copper-gold mine in Ecuador, targeted for production by the end of 2026.

For more information, visit the company’s website at www.SilvercorpMetals.com/welcome.

NOTE TO INVESTORS: The latest news and updates relating to SVM are available in the company’s newsroom at https://ibn.fm/SVM

Third-Party Content Disclaimer

The IBN website may contain third-party content articles and other content submitted by third parties, including articles submitted through the IBN Premium Partnership Program. All opinions, statements and representations expressed by such third parties are theirs alone and do not express or represent the views and opinions of IBN or its affiliates and owners. Content created by third parties is the sole responsibility of such third parties, and IBN does not endorse, guarantee or make representations concerning the accuracy and completeness of any third-party content. You acknowledge that by IBN providing you with this internet portal that makes accessible to you the ability to view third party content through the IBN site, IBN does not undertake any obligation to you as a reader of such content or assume any liability relating to such third-party content. IBN expressly disclaims liability relating to such third-party content. IBN and its members, affiliates, successors, assigns, officers, directors, and partners assume no responsibility or liability that may arise from the third-party content, including, but not limited to, responsibility or liability for claims for defamation, libel, slander, infringement, invasion of privacy and publicity rights, fraud, or misrepresentation, or an private right of action under the federal securities laws of the United States or common law. Notwithstanding the foregoing, IBN reserves the right to remove third-party content at any time in its sole discretion. By viewing this third-party content, you acknowledge that you have viewed, read fully, accepted and agreed to all terms of the Disclaimer at https://IBN.fm/Disclaimer.

• The company is advancing three Nova Scotia community solar projects, in Sydney, Brooklyn, and West Petpeswick, expected to power the equivalent of 1,140 homes annually.
• Combined project output will total approximately 14,369 MWh of clean energy per year, and could reduce roughly 10,058 tonnes of CO2 annually, equivalent to removing 3,081 passenger vehicles from the road.
• Lifetime savings for local communities are estimated at $6.95 million.
• Construction is set to begin in spring 2026, pending interconnection results and financing.

Disseminated on behalf of PowerBank Corporation

PowerBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., announced it is progressing with three community solar projects in Nova Scotia. The developments, located in Sydney, Brooklyn, and West Petpeswick, are expected to move into construction by spring 2026, once interconnection results are finalized and financing secured (https://ibn.fm/KEBUi).

According to the company, the projects will generate a combined 12.4 MW DC of solar power, contributing to Nova Scotia’s target of sourcing 80% of its electricity from renewables by 2030. Together, they will supply approximately 14,369 megawatt hours annually, enough to power the equivalent of 1,140 homes.

Unlike rooftop systems that require upfront investment and property ownership, community solar allows residents, renters, and businesses to subscribe directly to solar farms. Subscribers receive bill credits worth roughly $0.02 per kilowatt-hour, offering an accessible path to renewable energy without installation costs.

The projects will connect directly to the local grid, broadening access to clean energy and supporting Nova Scotia’s transition away from fossil fuels. This structure also provides flexibility for communities and small businesses that otherwise lack the resources to install solar infrastructure.

Over their lifetime, the three projects are expected to deliver up to $6.95 million in combined electricity savings for the participating communities. The company underlined that the projects will bring additional benefits, including local job creation, improved grid reliability, and emissions reductions of roughly 10,058 tonnes of CO2, equivalent to taking 3,081 cars off the road.

The projects are owned by the AI Renewable Flow-through Fund and will be engineered in collaboration with Trimac Engineering, a Nova Scotia-based firm. PowerBank is the lead developer and builder.

Canada’s federal government and the Province of Nova Scotia have created incentive frameworks to support projects of this type. Programs such as the Smart Renewables and Electrification Pathways Program (“SREPs”), Indigenous-Led Clean Energy Stream, and Low Carbon Communities initiative are designed to encourage community participation in renewable energy development.

Nova Scotia has awarded just four community solar contracts so far, with PowerBank’s three projects accounting for a substantial portion of the province’s planned 100 MW AC of solar capacity additions.

PowerBank has completed over 100 MW of projects across North America and maintains a development pipeline exceeding one gigawatt. Until now, much of its activity has been concentrated in the U.S. community solar sector, especially in the upstate New York area, where it has delivered more than 50 MW of projects. The Nova Scotia initiative marks a significant step in extending its presence in Canada’s emerging clean energy market.

By leveraging its modular development model and experience with distributed solar, PowerBank expects to generate engineering, procurement, and construction revenue from these projects in the near term while establishing a foothold for additional contracts in Atlantic Canada.

For more information, visit the company’s website at https://PowerBankCorp.com.

This report contains forward looking information. Please refer to the press releases entitled “PowerBank (SUUN) Advances Three Nova Scotia Community Solar Projects” and dated September 17, 2025, for additional details on the information, risks and assumptions.

NOTE TO INVESTORS: The latest news and updates relating to SUUN are available in the company’s newsroom at https://ibn.fm/SUUN

• Following StubHub’s recent IPO valuation, SEGG Media highlights its recent acquisitions in the booming live entertainment and ticketing industries
• SEGG Media announced a global partnership with Dods Diving League (“DDL”) to deliver not only competitions, but also original content and interactive features to engage fans
• A recent Noble Capital Markets report gave SEGG Media an Outperform rating and a $20 price target, which values the company over $100 million

SEGG Media (NASDAQ: SEGG, LTRYW), a sports, entertainment and gaming company, recently highlighted its acquisition of Concerts.com and TicketStub.com.

This came after StubHub priced its IPO at $23.50, giving the company a nearly $9 billion valuation at the time, a figure that has since retreated, but initially drew plenty of eyes to the ticket exchange, live entertainment, and ticket resale industries.

The global live entertainment industry, as well as primary and secondary ticketing markets, are booming, and with SEGG Media recently acquiring a 51% controlling stake in DotCom Ventures Inc., the company that owns Concerts.com and TicketStub.com, it positions itself to capitalize on this growing market.

The company confirmed that it’s working on updating both sites, to turn them into a state-of-the-art, user-friendly, and fan-centered platform and ticketing experience. 

The Chairman, President, and CEO of SEGG Media, Matthew McGahan stated that “StubHub’s $9 billion IPO move demonstrates the extraordinary value being placed on ticketing platforms by Wall Street. Our acquisition of Concerts.com and TicketStub.com was timely, strategic, and forms part of a wider vision to build an integrated live-entertainment ecosystem that combines ticketing, streaming, and sports media.”

In addition to highlighting these sites, SEGG Media recently announced a global partnership with Døds Diving League (“DDL”), which is the global platform for one of the world’s fastest growing extreme sports, which is all about leaping from impressive heights in style.

Sports.com Studios Ltd., the sports content subsidiary of SEGG Media, is managing the partnership, and it’s set to bring the excitement of the DDL to millions of fans across the globe.

SEGG Media becomes the global distribution partner for DDL events, and the company will also develop original content about the sport and create interactive features and content to engage fans and the global audience.

The moves the company is making are being noticed, as a recent Noble Capital Markets report gave SEGG Media an Outperform rating and a valuation over $100 million, which is more than four times SEGG Media’s current market cap. The report also gave the company a price target of $20 and cited the company’s impressive portfolio of brands and it’s Boca Raton Sports Complex as the assets that served as the foundation of this high valuation. It also points to the acquisitions and investments that the company has made, as well.

McGahan spoke on this report and stated “Independent analysis now confirms what we’ve been building: SEGG Media is dramatically undervalued relative to its assets and growth pipeline. With Sports.com, Lottery.com, and Concerts.com, we’ve created a solid three-pillar foundation, and as acquisitions close, we see significant upside in shareholder value.”

SEGG Media Corporation is a global sports, media, and gaming organization that seeks to connect fans to the games and experiences they love and create unforgettable experiences. It owns a portfolio of several digital assets like Sports.com, Lottery.com, Concerts.com, and others.

For more information, visit the company’s website at SEGGMediaCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to SEGG are available in the company’s newsroom at https://ibn.fm/SEGG

• LaFleur Minerals is a Canadian gold explorer and near-term producer with a fully owned mill onsite at its Quebec Abitibi Belt Project
• The company recognizes that the uniquely located Beacon Gold Mill represents a much-needed resource for neighboring mining projects who have already expressed an interest in custom milling agreements
• LaFleur expects to have the mill restarted in early 2026 following completion of a few basic upgrades
• LaFleur also anticipates using the mill operation for its own production as anticipated mining for mineralized material gets under way at the company’s Swanson Gold Project

The assets held by gold exploration and development company LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) amount to a way for investors to get into the gold market even if they aren’t eager to buy into precious metals commodities during the current record price trend.

LaFleur is exploring the potential of the approximately 18,304 hectares (45,230 acres) at its Swanson Gold Project in Quebec, strategically situated on Canada’s Abitibi Greenstone Belt, but the company also anticipates that its 100%-owned Beacon Gold Mill will drive near-term revenues simply by being available to process mineralized material from other nearby mines and deposits in the region at a time when the rising market has been reporting repeated new record pricing (https://ibn.fm/MZsj8).

J.P. Morgan Research analysts have forecast a potential continuation of the market trend, anticipating gold prices over $4,000 per ounce by next year (https://ibn.fm/GgzoO). Other analysts question if gold’s rapid rise indicates it is approaching the point of forming a bubble (https://ibn.fm/SYUnh). Either way, LaFleur’s strategic approach to building capital shows a readiness to make the most of the market.

The Beacon Gold Mill is capable of processing over 750 metric tons of raw ore per day. The mill had received more than $20 million in equipment and other upgrades by a former owner and is preparing for an estimated $3-5 million in restart upgrades that will improve its tailings pond and facility.

“We recently had an engineering group go in and do a full valuation on it … and they concluded it was in excellent condition,” LaFleur CEO Paul Ténière said during a Crux Investor interview last month (https://ibn.fm/Y3fSD).

“We anticipate roughly four to six months to get the full ramp-up completed and back into production. So we’re aiming for sort of early 2026 to be back in full production,” he added. “We’ve had lots of companies ask us about it, and it’s sort of the, you know, get it going and they will come. They want to see the mill back up and running — they say, ‘Hey, … we’d be interested in potentially doing agreements with you for processing box samples or even custom milling.”

While the near-term revenue strategy is expected to get the company up and rolling, LaFleur is still building toward mining its own mineralized material and processing it through the Beacon plant. With a greater measure of control over its own processes, low restart cost to production and with a fully integrated model of resource to production, the company can maximize its appeal to investors.

The company began drilling at its site this summer, and core logging shows the consistent presence of pyrite and other sulfides that are classic pathfinder minerals for gold, with initial assays from the 5,000 metre drilling program at Swanson to be announced near-term.

“We’re particularly optimistic about the mineralized zone encountered in hole SW-025-038 (a sulphide-rich zone known to be at least 17.9 meters wide) and we look forward to releasing assay results in the near future,” Ténière stated in an Aug. 7 news release (https://ibn.fm/aSNTi).

LaFleur has filed an updated NI 43-101 Technical Report for the project dated July 29.

For more information, visit the company’s website at LaFleurMinerals.com.

NOTE TO INVESTORS: The latest news and updates relating to LFLRF are available in the company’s newsroom at https://ibn.fm/LFLRF

Qualified Person Statement:

All scientific and technical information contained in this article has been reviewed and approved by Louis Martin, P.Geo. (OGQ), Exploration Manager and Technical Advisor of the company and considered a Qualified Person for the purposes of NI 43-101.

• Phase One drilling at Santa Fe delivers shallow oxide intercepts including 89.9 meters grading 0.23 g/t Au at York and 39.6 meters grading 0.30 g/t Au at Slab
• Second high-grade York zone discovered 18.3 meters grading 0.73 g/t Au, including 12.2 meters at 1.0 g/t Au, confirming new structural controls
• Warrant acceleration could provide $1.7 million in proceeds, reinforcing Lahontan’s ability to fund ongoing exploration and development

The gold development sector continues to walk a fine line between exploration success and financial strength. Investors look for companies that can expand resources while maintaining the capital to move projects toward production. Nevada, with its mining-friendly jurisdiction and extensive infrastructure, remains a prime location for this balancing act. Lahontan Gold (TSX.V: LG) (OTCQB: LGCXF) is currently exemplifying this dynamic through positive drill results at its Santa Fe Mine project and a concurrent warrant acceleration that bolsters its balance sheet.

Drilling Extends Santa Fe’s Resource Potential

Lahontan’s Phase One 2025 reverse-circulation drilling program at Santa Fe tested both the York and Slab zones, returning multiple intercepts that validate and extend the project’s resource model.

At York, hole YOR25-001R delivered a standout 89.9 meters grading 0.23 g/t gold from just 45.7 meters depth, confirming a thick, shallow oxide zone with strong continuity. The intercept expands the resource footprint east of the current pit shell and demonstrates clear potential for pit expansion.

A second hole, YOR25-002R, cut 18.3 meters grading 0.73 g/t gold, including 12.2 meters at 1.0 g/t gold, before ending in mineralization. This result highlights the importance of the York Fault as a structural control and suggests the gold system remains open both along strike and down-dip, creating targets for follow-up drilling.

At the Slab zone, hole CAL25-004R intersected 39.6 meters grading 0.30 g/t gold beneath the existing open pit. Geometry suggests a stacked horizon of oxide mineralization mirroring the overlying resource, which could extend pit depths and enhance mine economics without significantly increasing stripping ratios.

Financial Strength Through Warrant Acceleration

Complementing the drill results, Lahontan announced the acceleration of warrants issued earlier in 2025. The company triggered acceleration provisions after shares traded above $0.12 CAD for 10 consecutive days, allowing it to move the expiry date up to October 21, 2025.

If all outstanding warrants are exercised, Lahontan stands to receive approximately $1.7 million in proceeds. Management has indicated these funds will support working capital, exploration, and continued project advancement. This financing option avoids the dilution often associated with new capital raises while signaling investor confidence in Lahontan’s trajectory.

Strategic Integration: Results and Capital

The dual catalysts of drilling success and capital inflow reinforce each other. Positive results expand Santa Fe’s potential, supporting share price performance that in turn enables warrant exercises, creating a self-sustaining cycle of exploration and funding.

Lahontan is now planning Phase Two drilling at both York and Slab later this year, targeting down-dip and strike extensions. With NI 43-101 resource already exceeding 1.9 million ounces gold equivalent and new discoveries in hand, the company is positioned to add meaningful ounces while advancing toward development milestones.

Nevada Advantage

Nevada’s Walker Lane has a long track record of production, and Santa Fe benefits from historical output of 359,202 ounces of gold and 702,067 ounces of silver between 1988 and 1995. Existing infrastructure and a favorable jurisdiction help reduce development risk and capital requirements, supporting Lahontan’s plan to update its Preliminary Economic Assessment and continue advancing Santa Fe toward production.

Outlook

Lahontan’s combination of drilling success and strengthened financial flexibility highlights its ability to execute across both exploration and development fronts. With stacked zones at Slab, expanded mineralization at York, and $1.7 million in potential warrant proceeds, the company is positioned to accelerate its growth trajectory.

For more information, visit the company’s website at www.LahontanGoldCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to LGCXF are available in the company’s newsroom at ibn.fm/LGCXF

• GlobalTech recently closed a $1.4 million private placement of convertible notes to augment its growth and expansion plans.
• GLTK envisions advancing data-driven and AI-powered platforms across identified markets with solid growth potential.
• These updates highlight the company’s ongoing efforts toward uplisting on a national exchange and its overall expansion plans.

GlobalTech (OTC: GLTK), an American-headquartered tech-holding company with a specialty in big data, AI, and digital infrastructure, recently announced that it closed a $1.4 million private placement offering of promissory notes. This deal represents a big step for the firm as it increases efforts to achieve its growth and expansion vision. These notes, which are structured not to accrue interest except when in default, can be automatically converted to shares of common stock through an IPO at a discount to the original price (ibn.fm/4JAbF).

GLTK aims to leverage the funds raised to speed up its growth and expansion objectives. Some key areas expected to benefit from the funding include efforts aimed at promoting data-driven platforms and AI-powered solutions, as well as making further inroads into potentially lucrative global markets. The money raised also helps GlobalTech’s case toward being uplisted on a national securities exchange.

This financing, coupled with the company’s recently published 2025 Q2 financial report, indicates significant progress for the company. GLTK experienced a year-over-year revenue growth of 23.3% (about $5.63 million) backed by a 39% increase in international termination minutes and impressive telecom services.

The company has so far established a strong reputation as one to watch in the emerging tech space, with footprints in Europe, North America, South Asia, and the Middle East. GlobalTech’s model hinges on helping businesses unlock their potential by providing access to the latest relevant technologies and markets, resulting in exponential growth.

GLTK operates with a clear vision backed by a strategy that harmonizes innovation with capital inflows. Through its expertise in big data, artificial intelligence, and the emerging digital infrastructure, GlobalTech is creating systems capable of revolutionizing industries as it continues to consilidate its position in the global tech landscape.

GlobalTech’s latest funding updates underscore the company’s mission to unlock the potential of its portfolio companies by providing access to AI-driven platforms, capital markets, and technology. The company’s projection towards a future IPO strategically positions it as an emerging powerhouse in the tech ecosystem.

D. Boral Capital LLC, a top New York-based investment bank, served as the company’s GlobalTech’s strategic advisor for this deal, buttressing the reach and credibility of GLTK’s fundraising strategy (ibn.fm/v9jBa).

With an increased interest among investors in data and AI-driven solutions, GlobalTech’s path towards national exchange uplisting and expansion further solidifies its position as a force to be reckoned with in the global tech ecosystem.

For more information, visit www.GlobalTechCorporation.com.

NOTE TO INVESTORS: The latest news and updates relating to GLTK are available in the company’s newsroom at ibn.fm/GLTK